B03AD03
PolandFerrous sulfate
-
Tardyferon fol
Form: tablets, prolonged release
Active substance Dosage Ferrous sulfate 80 mg Folic acid 0.35 mg ATC code: B03AD03
Manufacturer: Pierre Fabre Medicament
-
Tardyferon-fol
Form: tablets, prolonged release
Active substance Dosage Ferrous sulfate 80 mg Folic acid 0.35 mg ATC code: B03AD03
Manufacturer: Pierre Fabre Médicament Portugal, Ltd.
-
Tardyferon-fol
Form: tablets, modified release
Active substance Dosage Ferrous sulfate 80 mg Folic acid 0.35 mg ATC code: B03AD03
Manufacturer: Pierre Fabre Medicament
-
Tardyferon-fol
Form: tablets, prolonged release
Active substance Dosage Ferrous sulfate 80 mg Folic acid 0.35 mg ATC code: B03AD03
Manufacturer: Pierre Fabre Médicament
-
Tardyferon-fol
Form: tablets, film-coated, prolonged release
Active substance Dosage Ferrous sulfate 80 mg Folic acid 0.35 mg ATC code: B03AD03
Manufacturer: Pierre Fabre Farmaka A.E.
-
Tardyferon-fol
Form: tablets, prolonged release
Active substance Dosage Ferrous sulfate 80 mg Folic acid 0.35 mg ATC code: B03AD03
Manufacturer: Pierre Fabre Medicament
-
Tardyferon-fol
Form: tablets, prolonged release
Active substance Dosage Ferrous sulfate 80 mg Folic acid 0.35 mg ATC code: B03AD03
Manufacturer: Pierre Fabre Médicament Portugal, Ltd.
-
Tardyferon-fol
Form: tablets, prolonged release
Active substance Dosage Ferrous sulfate 80 mg Folic acid 0.35 mg ATC code: B03AD03
Manufacturer: Pierre Fabre Médicament Portugal, Ltd.
-
Tardyferon-fol
Form: tablets, modified release
ATC code: B03AD03
Manufacturer: Pierre Fabre Medicament
-
Tardyferon-fol
Form: tablets, modified release
Active substance Dosage Ferrous sulfate 80 mg Folic acid 0.35 mg ATC code: B03AD03
Manufacturer: Pierre Fabre Medicament